未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏GFPC 06-2018: A multicentre phase II, open-label, non-randomized study evaluating platinum-pemetrexedatezolizumab ( plus /- bevacizumab) for patients with stage IIIB/IV non-squamous NSCLC with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies
Bylicki, O.; Gervais, R.; Monnet, I.; Ricordel, C.; Bigay-Game, L.; Geier, M.; Decroisette, C.; Daniel, C.; Guisier, F.; Swalduz, A.; Toffart, A. C.; Doubre, H.; Peloni, J. M.; Arpin, D.; Morel, H.; Veillon, R.; Clarisse, B.; Martins-Lavinas, P-H.; Greillier, L.; Chouaid, C.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Quantifying treatment preferences and their association with financial toxicity in women with breast cancer
Williams, Courtney P.; Gallagher, Kathleen D.; Deehr, Katie; Aswani, Monica S.; Azuero, Andres; Daniel, Casey L.; Ford, Eric W.; Ingram, Stacey A.; Balch, Alan J.; Rocque, Gabrielle B.
分享
收藏
分享
收藏Skin Cancer Early Detection Practices among Adult Survivors of Childhood Cancer Treated with Radiation
Geller, Alan C.; Keske, Robyn R.; Haneuse, Sebastien; Davine, Jessica A.; Emmons, Karen M.; Daniel, Casey L.; Gibson, Todd M.; Marghoob, Ashfaq; Mertens, Ann C.; McDonald, Aaron J.; Robison, Leslie L.; Howell, Rebecca M.; Whitton, John A.; Coroiu, Adina; Leisenring, Wendy M.; Armstrong, Gregory T.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏